Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 5/20 | 0.38 |
| ▸ | RAB9A | P51151 | 5/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6848121 | 0.95 | CA1 (0.42) | KDM4EHPGDMAPTALDH1A1HSD17B10 | |
| SCHEMBL6751468 | 0.86 | KDM4E (0.45) | KDM4EHPGDMAPTALDH1A1HSD17B10 | |
| SCHEMBL6841187 | 0.85 | KDM4E (0.42) | KDM4EHPGDMAPTALDH1A1HSD17B10 | |
| SCHEMBL12377360 | 0.84 | ALDH1A1 (0.39) | KDM4EMAPTALDH1A1APPENPP3 | |
| SCHEMBL6846549 | 0.84 | NPC1 (0.35) | KDM4EHPGDMAPTALDH1A1HSD17B10 | |
| SCHEMBL6848411 | 0.84 | ALDH1A1 (0.39) | KDM4EMAPTALDH1A1APPENPP3 | |
| SCHEMBL6749627 | 0.84 | KDM4E (0.42) | KDM4EHPGDMAPTALDH1A1HSD17B10 | |
| SCHEMBL23308936 | 0.84 | ESR2 (0.45) | KDM4EHPGDMAPTALDH1A1HSD17B10 | |
| SCHEMBL2511345 | 0.83 | ESR2 (0.56) | KDM4EHPGDMAPTALDH1A1HSD17B10 | |
| SCHEMBL2213226 | 0.83 | ESR2 (0.56) | KDM4EHPGDMAPTALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6696588-B2 | OXIDATION POTENTIAL OF .3-1.5 V ON THE BASIS OF A STANDARD HYDROGEN ELECTRODE, ALKOXY AND AROMATIC AMINE DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-02-24 | — | — | US | disclosed |
| EP-0861845-B1 | Silicon-containing compound and organic electroluminescence device using the same | SUMITOMO CHEMICAL CO (JP) | 2003-05-28 | — | — | EP | disclosed |
| US-20020115877-A1 | Silicon-containing compound and organic electroluminescence device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2002-08-22 | — | — | US | disclosed |
| US-6369258-B1 | SILICON COMPOUND WITH OXIDATION POTENTIAL ON HYDROGEN ELECTRODE POTENTIAL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-09 | — | — | US | disclosed |
| EP-0861845-A2 | Silicon-containing compound and organic electroluminescence device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115877-A1 | Silicon-containing compound and organic electroluminescence device using the same | EPCAM, PIEZO1, OR10J3 | KDM4E 296/4885HPGD 4102/4885MAPT 1203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.